ONO PHARMACEUTICAL - Common Stock - Foreign

Historical Portfolio Holders from Q4 2015 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / Common Stock - Foreign
Shares, excl. options Q1 2024
233 K
Holdings value Q1 2024
$3.81 M
Value change Q1 2024
+$509 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
1
Number of buys Q1 2024
1
Number of sells Q1 2024
0
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0
CUSIP
006660107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 233 K $3.81 M +$509 K $16.36 1
2023 Q4 202 K $3.61 M +$3.61 M $17.84 1
2023 Q2 127 K $2.29 M +$2.23 M $18.06 1
2023 Q1 3.69 K $76.8 K +$2.44 K $20.82 1
2022 Q4 3.57 K $83.9 K +$83.9 K $23.49 1
2020 Q4 27.4 K $825 K $0 $30.10 1
2020 Q3 27.4 K $858 K +$65.7 K $31.31 1
2020 Q2 25.3 K $736 K $0 $29.08 1
2020 Q1 25.3 K $583 K +$242 K $23.03 1
2019 Q4 14.8 K $341 K $0 $23.02 1
2019 Q3 14.8 K $268 K $0 $18.11 1
2019 Q2 14.8 K $265 K $0 $17.93 1
2019 Q1 14.8 K $290 K +$39.2 K $19.60 1
2018 Q4 12.8 K $262 K $0 $20.46 1
2018 Q3 12.8 K $362 K $0 $28.30 1
2018 Q2 12.8 K $300 K $0 $23.45 1
2018 Q1 12.8 K $396 K $0 $30.97 1
2017 Q4 12.8 K $298 K $0 $23.31 1
2017 Q3 12.8 K $290 K $0 $22.65 1
2017 Q2 12.8 K $279 K $0 $21.81 1
2017 Q1 12.8 K $265 K +$234 K $20.68 1
2016 Q4 1.5 K $32.9 K $0 $21.91 1
2016 Q3 1.5 K $41.6 K $0 $27.71 1
2016 Q2 1.5 K $64.8 K $0 $43.20 1
2016 Q1 1.5 K $63.6 K +$50.9 K $42.40 1
2015 Q4 300 $54.1 K +$54.1 K $180.31 1